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Abstract
Background: The extent of similarity between consolidation and reconsolidation is not yet fully
understood. One of the differences noted is that not every brain region involved in consolidation
exhibits reconsolidation. In trace fear conditioning, the hippocampus and the medial prefrontal
cortex (mPFC) are required for consolidation of long-term memory. We have previously
demonstrated that trace fear memory is susceptible to infusion of the protein synthesis inhibitor
anisomycin into the hippocampus following recall. In the present study, we examine whether
protein synthesis inhibition in the mPFC following recall similarly results in the observation of
reconsolidation of trace fear memory.
Results: Targeted intra-mPFC infusions of anisomycin or vehicle were performed immediately
following recall of trace fear memory at 24 hours, or at 30 days, following training in a one-day or
a two-day protocol. The present study demonstrates three key findings: 1) trace fear memory does
not undergo protein synthesis dependent reconsolidation in the PFC, regardless of the intensity of
the training, and 2) regardless of whether the memory is recent or remote, and 3) intra-mPFC
inhibition of protein synthesis immediately following training impaired remote (30 days) memory.
Conclusion: These results suggest that not all structures that participate in memory storage are
involved in reconsolidation. Alternatively, certain types of memory-related information may
reconsolidate, while other components of memory may not.
Background
Protein synthesis dependency around the time of training
is a hallmark of long-term memory consolidation [1].
This has been repeatedly demonstrated across species and
types of new information learned [2]. Reactivation of
information already committed to long-term memory
may induce an additional protein synthesis dependent
period, during which the original memory can be dis-
turbed by administration of protein synthesis inhibitors,
suggestive of a reconsolidation process [3], although alter-
native interpretations have been suggested [4]. While pro-
tein synthesis dependencies have been observed for both
consolidation and reconsolidation, evidence suggests that
consolidation and reconsolidation differ in several key
aspects (for review see [5])[6]. For example, a protein syn-
thesis-dependent period follows every training paradigm
(consolidation), whereas not every reactivation of mem-
ory results in a re-dependency on protein synthesis
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(reconsolidation). Whether a reactivated memory under-
goes reconsolidation appears to depend on several factors,
including the age of the memory and training intensity
[7,8] For example, a conditioned taste aversion (CTA)
memory resulting from a more intense, two day, training
protocol is susceptible to reconsolidation, whereas a one
day training paradigm results in a memory susceptible to
extinction [8]. An additional key difference is that not all
brain regions involved in consolidation are involved in
reconsolidation. For example, in inhibitory avoidance,
protein synthesis in the dorsal hippocampus is required
for consolidation but not reconsolidation of memory [9].
Similarly, in CTA, consolidation depends on protein syn-
thesis in the central nucleus of the amygdala, whereas
there is no renewed protein synthesis dependency in this
region following memory reactivation [10]. In young
chicks, following a reminder, expression of the transcrip-
tion factor c-Fos is seen only in one of the two regions
involved in consolidation [11], further suggesting that not
all structures involved in consolidation participate in
reconsolidation.
Trace fear conditioning is a form of learning that involves
the association between a tone (conditioned stimulus,
CS) and a footshock (unconditioned stimulus, US) that
are separated by a time gap (trace period). The hippocam-
pus and the medial prefrontal cortex (mPFC) are required
for making the CS-US association, and both are required
for consolidation of memory for trace fear conditioning
[12-17] We have recently reported that, in addition to its
role in consolidation of trace fear memory, the hippocam-
pus is a site of renewed protein synthesis dependency fol-
lowing trace fear memory reactivation [18]. Consistent
with previous reports, only a more intense (two day)
training protocol resulted in a memory susceptible to
reconsolidation, whereas a one day training resulted in a
memory susceptible to extinction. In the present study, we
examine whether the mPFC is also a site of protein synthe-
sis dependent reconsolidation following reactivation of
trace fear memory for one- or two-day training paradigms.
Results
Inhibition of prefrontal protein synthesis following recall of 
a one-day trace fear conditioning paradigm does not 
disrupt memory
Animals were given a one-day training session consisting
of eight CS-US paired trials (Fig. 1A). A 24-hour time
point for reactivation has been previously used to show
hippocampal reconsolidation for contextual, and trace
fear conditioning [18,19]. Therefore, the animals were
presented with one CS-alone reactivation trial within a
novel context, 24 hours following training (Fig. 1A).
Immediately following the memory reactivation trial, ani-
mals received bilateral intra-mPFC infusions of either 250
µg of anisomycin, or an equal volume (2 µl) of vehicle.
The amount of anisomycin used in this study has previ-
ously been shown to inhibit >90% of protein synthesis,
and is sufficient to impair consolidation [20,21] Addi-
tionally, infusion of this dose into the hippocampus was
sufficient to observe reconsolidation of contextual [19],
and trace fear conditioning [18].
During the reactivation trial, the animals demonstrated
freezing behavior at a level comparable to the level
acquired during training. Minimal freezing was observed
in the novel context prior to CS presentation (pre-CS) and
during CS presentation. A significant increase in freezing
behavior during the trace period (Fig. 1B). Immediately
following the reactivation trial, animals were divided into
two comparable groups based on freezing behavior dur-
ing the trace period of the reactivation trial, and one group
was bilaterally infused with anisomycin (250 ug/2 ul per
mPFC), while the other received vehicle (2 ul per mPFC)
(trace period freezing: anisomycin n = 10: react = 82.5 ±
8.0 %; vehicle n = 9: react = 90.0 ± 6.0 %; n.s.). Retention
was tested two days following reactivation by exposing the
animals to four CS-alone trials and measuring trace
period freezing. The two groups both remembered that
the termination of the CS predicts the subsequent foot-
shock as demonstrated by an increase in fear during the
trace period as compared to that seen in either the pre-CS
or the CS periods. However, the freezing percentage
recorded for the anisomycin-infused animals during these
time periods did not differ from that observed in the
saline-treated controls (trace period freezing: anisomycin
n = 10: retention = 65.8 ± 13.0 %; vehicle n = 9: retention =
77.8 ± 11.3 %; n.s.) (Fig. 1B–C), indicating no disruption
in memory due to the protein synthesis inhibition. Con-
textual fear, assessed by placing the animal back into the
original training chamber, also did not differ between the
two groups (data not shown).
Inhibition of prefrontal protein synthesis following recall of 
a two-day trace conditioning paradigm does not disrupt 
memory
We have previously shown that two consecutive days of
trace fear training results in a memory which is susceptible
to reconsolidation within the hippocampus [18]. To test if
this protocol influences the susceptibility of the mPFC to
protein synthesis inhibition following reactivation of
trace fear memory, animals were given two eight-trial
training sessions over two consecutive days. Twenty-four
hours following the second training session, animals were
given one CS-alone reactivation trial in a novel context,
divided into two comparable groups, and bilaterally
infused with either anisomycin (250 ug/2 ul per mPFC) or
vehicle (2 ul per mPFC) (Fig. 2A–B). Retention was tested
two days following reactivation by exposing the animals
to four CS-alone trials and measuring trace period freez-
ing. As observed in the one-day training paradigm, but inBMC Neuroscience 2006, 7:67 http://www.biomedcentral.com/1471-2202/7/67
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contrast to that previously observed in the hippocampus,
the groups did not differ from each other in freezing dur-
ing the trace period, with both groups displaying memory
comparable to that during the reactivation trial (trace
period freezing: anisomycin: retention  = 87.14 + 5.22,
vehicle: retention = 79.17 + 10.20, n.s.) (Fig. 2C). No dif-
ference in percent freezing between the groups was
detected in either pre-CS or CS periods (Fig 2C), nor in
context-specific fear (data not shown).
Inhibition of prefrontal protein synthesis following remote 
recall of a two-day trace fear conditioning paradigm does 
not disrupt memory
Models of hippocampus-dependent memory consolida-
tion posit that memory is initially dependent on the hip-
pocampus, and remote memories are supported by
neocortical regions (such as the mPFC) independently of
the hippocampus [22-24]. The time scale of the switch
from hippocampal to neocortical dependency is thought
Inhibition of prefrontal protein synthesis following recall of a one-day trace fear conditioning paradigm does not disrupt mem- ory Figure 1
Inhibition of prefrontal protein synthesis following recall of a one-day trace fear conditioning paradigm does 
not disrupt memory. A, Scheme illustrating the chronology of training (CS-US), reactivation 24 hours later, intra-mPFC 
infusion, and retention testing in a novel context two days following the infusions. B, Graph of the mean percent freezing ± 
standard error of the mean (SEM) before CS presentation, during CS presentation, and during the trace period of the reactiva-
tion trial. Animals were infused with 2 ul of either anisomycin or vehicle directly into the mPFC, immediately following the 
reactivation trial. C, Graph of the mean ± SEM percent freezing before CS presentation, to the CS, and during the trace period 
of the retention testing trials for intra-mPFC anisomycin- and vehicle-infused groups, expressed as an average of four trials.BMC Neuroscience 2006, 7:67 http://www.biomedcentral.com/1471-2202/7/67
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to be several weeks to a month in rodents [25-27]
Although it has been recently demonstrated that memory
storage within the mPFC occurs as a direct result of trace
fear conditioning [16], it is still possible that reactivation
of this memory at a time point beyond hippocampal
dependency may be required to observe reconsolidation
in this brain region. To test whether reactivation of remote
memories induces protein synthesis dependent reconsoli-
dation, animals were given eight CS-US pairings, on two
consecutive days (Fig. 3A). Thirty days following training,
memory was reactivated by exposing the animals to one
CS-alone reactivation trial in a novel context (Fig. 3A).
Immediately following the reactivation trial, animals were
divided into two comparable groups (anisomycin: react =
90.0 ± 2.7%; vehicle: react=96.7 ± 1.7%, n.s.) (Fig. 3B),
then bilaterally infused into the mPFC with either ani-
somycin or vehicle. Retention was tested two days follow-
ing reactivation (32 days after training) by exposing the
animals to four CS-alone trials and measuring trace
period freezing. There was no difference between the
groups during the retention trial in either the pre-CS, CS,
or trace periods (trace period freezing: anisomycin: reten-
tion = 74.4 + 6.9%; vehicle: retention = 74.7 + 6.8%, n.s.)
(Fig. 3C). No difference between the two groups in con-
textual fear was observed (data not shown).
Although the dose of anisomycin used in the present
study has been employed by several laboratories, includ-
Inhibition of prefrontal protein synthesis following recall of a two-day trace conditioning paradigm does not disrupt memory Figure 2
Inhibition of prefrontal protein synthesis following recall of a two-day trace conditioning paradigm does not 
disrupt memory. A, Scheme illustrating two training sessions (eight CS-US pairings on two consecutive days), reactivation 
24 hrs following the second day of training, intra-mPFC infusion, and retention testing in a novel context. B, Summary data of 
the percent freezing during the pre-CS, CS and trace periods of the reactivation trial for intra-mPFC anisomycin- and vehicle-
infused groups. C, Percent freezing displayed during the retention testing trials (pre-CS period, to the CS, and during the trace 
periods) for intra-mPFC anisomycin- and vehicle-infused groups. Data is expressed as the mean of four trials ± SEM.BMC Neuroscience 2006, 7:67 http://www.biomedcentral.com/1471-2202/7/67
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ing ours, to evaluate reconsolidation, the absence of a
reconsolidation effect in the mPFC may have resulted
from insufficient protein synthesis inhibition. As consoli-
dation has been repeatedly demonstrated to be dependent
on de novo protein synthesis, the influence of anisomycin
on mPFC memory storage was examined. Animals were
trained in trace fear conditioning (Fig 4A). Figure 4B
shows that animals acquired the conditioned repsonse as
in indicated by increased freezing during the trace period.
Immediately after completion of training, rats were ran-
domly divided into two groups and infused with either
anisomycin (at a dose of 160 µg per side), or an equal vol-
ume of vehicle directly into the mPFC. Thirty days follow-
ing the training and infusion, retention of remote trace
fear memory was tested by examining percent freezing in
response to four cue presentations. Figure 4C shows that
both groups displayed similar levels of freezing to the
novel context (pre-CS) and to the CS. However, a signifi-
cant reduction in freezing during the trace period was
observed in the anisomycin-infused group by comparison
to the vehicle-infused controls [vehicle (n = 8): 87.86 +
2.91; anisomycin (n = 10): 63.00 + 8.75; p < 0.05], (Fig
4C). This difference in trace fear could have arisen from a
fortuitous sorting of the animals prior to anisomycin or
vehicle infusion. To address this possibilty, we re-exam-
ined the acquisition curves of the conditioned animals
Inhibition of prefrontal protein synthesis following remote recall of a two-day trace fear conditioning paradigm does not dis- rupt memory Figure 3
Inhibition of prefrontal protein synthesis following remote recall of a two-day trace fear conditioning paradigm 
does not disrupt memory. A, Scheme illustrating the chronology of training sessions on two consecutive days (eight CS-US 
per day), reactivation at 30 days following training, intra-mPFC infusion, and retention testing in a novel context (two days fol-
lowing the infusions). B, Graph of the mean ± SEM percent freezing prior to CS presentation, during the CS, and during the 
trace period of the reactivation trial for intra-mPFC anisomycin- and vehicle-infused groups. C, Graph of the mean ± SEM per-
cent freezing during the pre-CS, CS and trace periods for the retention testing trials, expressed as an average of four trials.BMC Neuroscience 2006, 7:67 http://www.biomedcentral.com/1471-2202/7/67
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Inhibition of prefrontal protein synthesis following trace conditioning impairs consolidation Figure 4
Inhibition of prefrontal protein synthesis following trace conditioning impairs consolidation. A, Scheme illustrat-
ing the training, intra-mPFC infusion, and retention testing in a novel context 30 days following the training. B, Summary data 
showing the learning curves for animals during trace fear conditioning. Data is presented as the mean ± SEM for percent freez-
ing during the trace period. C, Percent freezing during the pre-CS, CS and trace periods of the reactivation trial for intra-mPFC 
anisomycin- and vehicle-infused groups. D, Summary data showing the learning curves of the vehicle- and anisomycin-infused 
animals during the trace conditioning paradigm. Data is presented as the mean ± SEM for percent freezing during the trace 
period. Data is presented as the mean ± SEM. *, P < 0.05.BMC Neuroscience 2006, 7:67 http://www.biomedcentral.com/1471-2202/7/67
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separated into their respective treatment groups. Figure
4D shows that there was no observable difference in the
learning curves between the two groups. Taken together,
these results demonstrate that anisomycin infusion into
the mPFC impairs memory consolidation for trace condi-
tioning, but that these memories do not appear to
undergo reconsolidation.
Following completion of behavioral studies, representa-
tive animals were examined for cannulae placement. The
infusion track termini were located in the PL cortex of the
mPFC in the animals examined (Fig. 5A–B). All of the
infusion sites were located within 0.35 mm (along the
raustro-caudal axis) of the target coordinates.
Discussion
Reconsolidation refers to the experimental observations
that following reactivation, a memory trace may once
again become susceptible to protein synthesis inhibition
[3,9,19] Although this is similar to the protein synthesis
dependency of initial stabilization or consolidation of
memory, one important distinction is that not every brain
region involved in consolidation is involved in reconsoli-
dation [9-11] In trace fear conditioning, memory for the
trace relationship is stored in both the hippocampus and
mPFC [16,28] We have recently demonstrated that inhibi-
tion of hippocampal protein synthesis following reactiva-
tion of trace fear memory results in reconsolidation [18].
In contrast, the present study demonstrates that memory
for trace fear conditioning does not undergo protein syn-
thesis-dependent reconsolidation in the mPFC, regardless
of the intensity of the training, and regardless of whether
the memory is recent or remote.
As we are reporting that we find no evidence of reconsoli-
dation in the mPFC, we have to consider the possibility
that this negative finding is due to an insufficient dose of
the protein synthesis inhibitor. Effects in reconsolidation
studies have previously been observed in structure-tar-
geted infusions of as little as 62.5 µg of anisomycin [3]. In
the present study, we infused four times this amount (250
µg), a dose that has previously been shown to result in
reconsolidation when infused into the hippocampus
immediately following reactivation [18,19]. Furthermore,
a dose of 160 µg anisomycin, two-thirds that used in the
reconsolidation experiments, was sufficient to impair
long-term consolidation within the mPFC. It is therefore
unlikely that insufficient protein synthesis inhibition
underlies the absence of a reconsolidation effect. Several
studies have suggested that specific reactivation condi-
tions may be required to induce reconsolidation in some
situations [29,30] For example, in an object recognition
task, reactivation of memory in the original context is
required in order to observe zif268 dependent reconsoli-
dation [30]. Although the present study did not identify
Sites of intra-mPFC anisomycin infusions Figure 5
Sites of intra-mPFC anisomycin infusions. A, Depiction 
of the mPFC on atlas plates at two different rostral-caudal 
planes modified from Swanson (2004). Non-redundant sites 
of infusion termini (marked by black circles) in the mPFC 
from a representative sample of animals. The horizontal bars 
mark the borders of the prelimbic (PL) cortex. None of the 
infusion tracks terminated in the infralimbic (IL) cortex. B, A 
representative photomicrograph of a coronal section stained 
with cresyl violet indicating the terminus of an infusion nee-
dle (shown by arrow). AC, anterior cingulate; ILA, infralimbic 
cortex; PL, prelimbic cortex; RF, rhinal fissure; Orb, medial 
orbital cortex.BMC Neuroscience 2006, 7:67 http://www.biomedcentral.com/1471-2202/7/67
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the specific conditions, if any, required for reconsolida-
tion in the mPFC, it demonstrated that the paradigm that
induces this phenomenon in the hippocampus is not
capable of causing reconsolidation in the mPFC.
At present, it is still debated whether reconsolidation is
analogous to a recapitulation of initial consolidation, if it
reveals a late component of the initial consolidation proc-
ess, or if it is related to memory retrieval (for review see
[31])[5,6]. Recently, it has been shown that impaired
memory as a result of inhibition of hippocampal protein
synthesis following memory recall can be rescued by a
reminder).)[32]. This, along with studies demonstrating
that memory impairments as a result of hippocampal
reconsolidation reverse over time [4,33]., suggests that the
memory deficits may result from a dysfunction in mem-
ory retrieval. The mPFC has several characteristics which
may explain the lack of reconsolidation in this structure,
regardless of whether reconsolidation reflects memory
storage or retrieval deficits. First, if we assume that recon-
solidation is reflective of a memory storage deficit, the
mPFC may serve a different function in memory storage
than the hippocampus. Most models of long-term mem-
ory consolidation for hippocampus-dependent memo-
ries, such as trace fear conditioning, posit that the
hippocampus plays a temporary role, and that remote,
long-lasting memories are dependent on neocortical areas
such as the mPFC. Although long-term plasticity is
observed in both the mPFC and the hippocampus as a
direct result of training, this does not imply that the mem-
ories stored in these structures are of equivalent strength.
It is possible that plasticity within the mPFC is more sta-
ble, and not susceptible to reconsolidation, allowing for
persistence of memory over months to years. Second, if
reconsolidation reflects a retrieval deficit, the absence of
reconsolidation in the mPFC may reflect the difference
between the roles played by the hippocampus and the
mPFC in this process. One possibility is that information
storage within the hippocampus may be involved in the
reactivation of various components of information stored
in other structures and memory reactivation results in pro-
tein synthesis-dependent modifications within the hip-
pocampus that are necessary for subsequent memory
retrieval of updated memories [5]. In contrast, in the trace
fear conditioning paradigm, the mPFC may be involved in
storing some aspect of the information that is retrieved
and, therefore, may not undergo reconsolidation. Finally,
we would like to point out that despite the fact that ani-
somycin has been the most widely used protein synthesis
inhibitor, both in consolidation and reconsolidation
experiments (for review see [2])[34], this inhibitor has a
number of non-specific effects, including apoptosis
[35,36]. At present, it is not known if these non-specific
influences may have contributed to the observation of
reconsolidation in the hippocampus, and its lack in the
mPFC. As more insight is gained into the processes under-
lying the observations of reconsolidation, it should
become possible to determine the differences between the
hippocampus and the mPFC in respect to their role in
reconsolidation.
Conclusion
The present study demonstrates three key findings: 1)
trace fear memory does not undergo protein synthesis
dependent reconsolidation in the PFC, regardless of the
intensity of the training, and 2) regardless of whether the
memory is recent or remote, and 3) intra-mPFC inhibi-
tion of protein synthesis immediately following training
impaired remote (30 days) memory.
Methods
Subjects
Male Sprague Dawley rats (Charles River Laboratory,
Wilmington, MA) weighing 250 to 300 gm were pair-
housed under temperature-controlled conditions with a
12 hr light/dark cycle. All rats were given ad libitum access
to water and food. Protocols regarding the training and
surgery of the animal subjects were approved by the Insti-
tutional Animal Welfare Committee and were in compli-
ance with NIH's Guide for Care and Use of Laboratory
Animals.
Surgery
Animals were anesthetized under 5% isoflurane with a 2:1
N2O/O2 mixture and then maintained under 2.5% isoflu-
rane with a 2:1 N2O/O2 mixture via a face mask. Twenty-
two gauge stainless-steel guide cannulae were implanted
into the mPFC (bregma + 3.2 mm, lateral ± 0.75 mm, and
depth -2.5 mm) using a stereotaxic device [37]. Animals
were given a ten-day rest period following surgery before
behavioral testing. For the 30 day reconsolidation study,
animals were trained in the trace fear conditioning task
first, and the guide cannulae were implanted ten days
prior to the reactivation/reconsolidation testing. This was
done to prevent excessive scar tissue formation, and drift
of the guide cannulae, which may occur over a one month
period. Infusion cannulae that extended 1.5 mm past the
end of the guide cannulae were used for drug infusions.
After the completion of all behavioral experiments, repre-
sentative animals were killed and the brains post-fixed in
a 4% paraformaldehyde solution for histological analysis
of cannulae location.
Pharmacological infusions
Anisomycin (Sigma, St. Louis, MO) was dissolved in 1 N
hydrochloric acid, neutralized with NaOH, and then
diluted in artificial cerebrospinal fluid (ACSF), pH 7.4.
Anisomycin was bilaterally infused into the mPFC (250
µg/2 µl per side for reconsolidation; 160 µg/side for con-
solidation), at a rate of 0.25 µl per minute. The dose ofBMC Neuroscience 2006, 7:67 http://www.biomedcentral.com/1471-2202/7/67
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250 µg/2 µl has previously been shown to be effective in
blocking reconsolidation [18,19]. Anisomycin was
infused immediately following a single CS-alone exposure
in a novel context (reactivation trial). Vehicle control infu-
sions consisted of the same volume ACSF with the same
pH as the anisomycin solution. Following the infusion,
the needle was left in place for two minutes to allow for
diffusion of the drug. All infusions were performed using
a motorized infusion pump (Stoelting, Wood Dale, IL).
Trace fear conditioning/recall
All behavioral tests were performed by an investigator
who was blind to the treatment groups. Animals were
placed in the training context (Habitest Unit, Coulbourn
Instruments, Allentown, PA) and given a 120 second
habituation period. Conditioning trials began with a 10
second tone (CS) followed by a 20 second trace period,
after which the animal received a 0.8 mA foot-shock (US)
for 0.7 seconds. Each CS-US paired training trial was sep-
arated by a pseudorandom inter-trial interval (ITI) that
varied between 1–4 minutes. A pseudorandom ITI was
used so that amount of time between foot-shocks could
not be used as a cue for the US. For reactivation of mem-
ory, animals were placed in a novel context, given a 120
second habituation period followed by one presentation
of the CS without the presentation of the US (CS-alone
reactivation trial). Immediately following the reactivation
trial, animals were divided into two comparable groups
based on freezing behavior during the trace period of the
reactivation trial. One group was bilaterally infused with
anisomycin and the other with vehicle. For retention test-
ing, each animal was placed in a novel context and given
a 120 second habituation period. In the absence of foot-
shock, four presentations of the CS were given separated
by a varied ITI period. During the retention and reactiva-
tion trials, freezing behavior (defined as the absence of all
movement excluding movement caused by respiration)
was measured during the CS, trace, and ITI periods. Freez-
ing behavior was recorded every two seconds during scor-
ing periods. Freezing behavior during the four CS
presentations was averaged for each animal. Following
trace CS-US retention testing; contextual retention was
measured by placing the animals back into the original
training context for a 90 sec period during which freezing
was scored, without exposure to the CS or US.
Statistics
A two-way repeated measures ANOVA was used to com-
pare the percentage of trace period freezing during reten-
tion testing between the anisomycin- and vehicle-infused
groups as well as to compare trace period freezing
between reactivation and retention trials, within and
between the groups. An unpaired t-test was used to com-
pare CS as well as contextual freezing between the ani-
somycin- and vehicle-infused groups. A p value of ≤ 0.05
was used as the criterion for statistical significance. Raw
data were used for all statistical analyses.
Abbreviations
CS, conditioned stimulus; CTA, conditioned taste aver-
sion; iti, intertrial interval; mPFC, medial prefrontal cor-
tex; PL/IL, prelimbic/infralimbic; US, unconditioned
stimulus.
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